Budget 2020 tax update for biotech and tech companies

Colin-Hailey-headshot-Confluence-tax

THE 2020 Budget was an interesting one, especially for biotech companies. Confluence Tax’s team presented the headline points during the company’s Post-Budget Briefing event held on March 12. The focus was on the main elements that will affect companies from a tax and finance perspective.

Read More

Entrepreneurs’ Relief and EMI: letter to HM Treasury

Given the speculation in the press regarding the withdrawal of Entrepreneurs’ Relief (ER), I wanted to bring to your attention that Enterprise Management Incentive (EMI) share options rely on ER for their tax efficiency, in enjoying a 10% rate of capital gains tax.

Read More

Enterprise Management Incentives (EMI) share options guide

Questions to ask for an EMI scheme

  Enterprise Management Incentives (EMI) share options guide COMPANIES in the biotech and tech spaces have a constant need to incentivise staff and build motivated teams to prepare them down the line for a sale or investment. Part of that process should include consideration of equity incentives and the tax implications of granting these share…

Read More

EMI share option schemes: being nice is being right

Share-schemes

PROFESSIONAL advisors wrestle with the issue of “who is your client?” and this is particularly true when it comes to drafting share option schemes. An EMI share option scheme needs to be a tax-efficient way to reward employees. However, it is also important that the employer, as the client, gets a scheme that works for them…

Read More